Journal of Clinical Psychopharmacology

Article	Citations
The Treatment of Iatrogenic Anorgasmia in a Male Patient on Clozapine for Treatment-Resistant Schizophrenia	40
Transitioning From a Standard Low-Dose to a Rapid Low-Dose Buprenorphine Initiation in a Hospital Setting—A Case Report	32
Better Approaches to Derisking Psychiatric Drug Development are Needed, Not New Funding Mechanisms	30
Author Index 2022	30
Postinjection Syndrome After Paliperidone?	28
Treatment of Cannabis Hyperemesis Syndrome Using Haloperidol in a Pregnant Patient	26
Pharmacokinetic-Interactions of BI 425809, a Novel Glycine Transporter 1 Inhibitor, With Cytochrome P450 and P-Glycoprotein Substrates	25
Erratum: What Is the Current State of Evidence Regarding Any Mood-Improving Properties of GLP-1 Receptor Agonists, and Are Psychiatrists Prescribing Them?	19
Hodgkin Lymphoma in Patients Receiving Clozapine Treatment	18
Impact of Adjuvant GLP-1RA Treatment on the Adherence of Second-Generation Antipsychotics in Nondiabetic Adults	18
Possibly Misleading Pharmaceutical Advertising On TV	17
Question	17
The Relationship Between Participant Pretreatment Clinical Presentation and the Quality of Psilocybin Experience	16
Plasma Concentrations of Tranylcypromine in Depressed Patients With Chronic Kidney Disease	16
Trazodone and Mianserin for Delirium	16
Clozapine Use Among Individuals With Schizophrenia Occurring on the Background of Intellectual Disability and Rare Genetic Variation	16
Comparison of Weight-Based Valproic Acid Dosing in Treatment of Mental Illness Among Obese and Nonobese Patients	16
Clozapine-Associated Myocarditis in a Patient With Poor Metabolism During Fast Titration	16
Polypharmacy Among Patients With Major Depressive Disorder and Co-occurring Substance Use Disorders in a Psychiatric Hospital Setting	16
Risperidone-Induced Priapism	15
Beneficial Effect of Quetiapine on Sleep, Anxiety, Depression and Myalgia Symptoms in a Patient With Post–COVID-19 Condition	15
Deciphering Mental Illness	15
Efficacy and Safety of Alpha-Lipoic Acid as an Adjunctive Therapy in Schizophrenia	14
Duloxetine-Associated Erosive Gastritis and Gastroesophageal Reflux	13
Postpartum Depression and Antibiotics Overuse in Pakistan: Exploring a Potential Nexus	13

Suicidal Ideation and Self-harming Thoughts With Valbenazine Use	13
Thoughts on the Value of Case Series in the Literature	13
Celebrating 70 Years of the First Publication on Antipsychotic Treatment in North America by Heinz E. Lehmann and Gorman E. Hanrahan: Would Their Methodology Still Be Conceivable?	13
Mirtazapine as a Treatment for Adolescent Depression and PTSD in Juvenile Detention Settings	13
The Cardiac Cost of Lithium	12
Zopiclone Discontinuation–Associated Transient Sleepwalking Behavior	12
Pharmacological Treatment and Cognition in Bipolar I Disorder	11
Escitalopram-Associated Drug Rash	11
Recognition of Clozapine-Associated Eosinopenia in Patients With Treatment-Resistant Schizophrenia	11
Predicting Metabolic Adverse Effects of Lithium in Bipolar Disorder	11
Drug Interaction Between Clozapine and Rifampicin	11
Treatment of Acute Intermittent Porphyria–Associated Anxiety Disorder With Gabapentin	10
Restless Legs Syndrome Associated With Brexpiprazole	10
Effect of Valproate Coprescription on Clozapine Pharmacokinetics in Clinical Practice	10
Clozapine for Severe Irritability in Children and Adolescents With Autism Spectrum Disorder	10
Plasma Clozapine and N-Desmethylclozapine (Norclozapine) Concentrations and the Clozapine/Norclozapine Ratio	9
Betamethasone-Associated Psychosis in a Pregnant Woman Diagnosed With Schizophrenia	9
Mood Swings and Irritability in a Patient With Cystic Fibrosis on Elexacaftor-Tezacaftor-Ivacaftor Therapy	9
Letter to the Editors in Response to: Flanagan RJ, Hunter S, Obee S, Reeves S. Plasma Clozapine and Norclozapine After Use of Either Crushed Tablets or Suspension Compared With Tablets	9
Clinical and Demographic Predictors of Early Clozapine Discontinuation Across Mood and Psychotic Disorders	9
Neuroleptic Malignant Syndrome Associated With Lurasidone	9
SALUTE TO OUR REVIEWERS	9
Severe Panic Disorder After Vaccination With the Pfizer-BioNTech Vaccine	9
Effect of Cigarette Smoking on Clozapine Dose and on Plasma Clozapine and N-Desmethylclozapine (Norclozapine) Concentrations in Clinical Practice: Erratum	9
Antidepressive Effectiveness of Amisulpride, Aripiprazole, and Olanzapine in Patients With Schizophrenia Spectrum Disorders	9
Atomoxetine as a Viable ADHD Treatment in Breastfeeding Mothers	9
A Case of Akathisia After Administration of a Very Low Dose of Mirtazapine	8
Use of Risperidone Long-Acting Injection in the Treatment of Anorexia Nervosa: A Case Report	8
The Clinical and Economic Burden of Tardive Dyskinesia in Israel	8
Fluvoxamine Augmentation of Clozapine and Dose-dependent Interaction Patterns	8
Successful Management of ECT-Resistant Interictal Psychosis With Clozapine	8
Improvement of Compulsive Shopping on Tirzepatide	8
Journal of Clinical Psychopharmacology Updates	8
Successful Treatment of Inappropriate Sexual Behavior and Disinhibition in Dementia With Paroxetine	8
Safety of Intranasal Esketamine Administration in Brugada Syndrome	8
Withania somnifera (Ashwagandha) as an Adjunctive Treatment to Antipsychotic Medications for Patients With Schizophrenia	7
Therapeutic Interventions and Clinical Outcomes Following Breakthrough Psychosis on Antipsychotic Maintenance Medication (BAMM)	7
Olanzapine-Associated Hyperbilirubinemia in an Adolescent With Autistic Spectrum Disorder Comorbid With Schizophrenia	7
Higher Neutrophil-to-Lymphocyte Ratio Is Associated With Better Response to Esketamine in Treatment-Resistant Depression	7
Question	7
CYP2D6 Phenotype as a Predictor of Adverse Drug Reactions in Patients Treated With Trazodone	7
Incorporating Real-World Treatment Data Into Clozapine's Product Label	7
Mania-Like Reaction Secondary to Sodium Oxybate	7
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RE104	7
Question	7
Use of Clozapine in Pregnancy	7
Haloperidol-Induced Brugada-Pattern Electrocardiogram—A Case Report and a Review of the Literature	7
Long-Term Course of Illness With Rapid-Cycling Bipolar Disorder	7
Rapid Reinitiation of Clozapine After Recent Discontinuation	7
Limitations in Recent Study of Clozapine Use During Pregnancy	6

Resolution of Catatonia With Cariprazine—A Case Report	6
Oculogyric Crisis Associated With Clozapine: Case Report and Review of Literature	6
Alpha Lipoic Acid for Schizophrenia	6
Mania Associated With Cariprazine	6
Use of Sublingual Atropine Drops in Clozapine-Associated Sialorrhea in an Adolescent Patient	6
A System for Rapidly Yet Rigorously Evaluating the Quality of Randomized Controlled Trials	6
A Withdrawal Syndrome After a Switch of Phenibut to Another γ-Aminobutyric Acid Agonist	6
Clozapine- and Lithium-Associated Myoclonus	6
Clozapine Use in Down Syndrome	5
Postinjection Delirium/Sedation Syndrome After Paliperidone Palmitate Injection in a Bipolar Affective Disorder Patient	5
Pharmacokinetics of Ketamine Transfer Into Human Milk	5
Atomoxetine Associated Activation Syndrome in Adolescent Patients With ADHD	5
Clozapine Associated Periorbital Edema in First Episode Psychosis	5
Subject Index 2022	5
Clozapine-Associated Agranulocytosis	5
Plasma Clozapine in Treatment Refractory Schizophrenia	5
Aripiprazole-Associated QT Prolongation in a Healthy Study Volunteer	5
Question	5
Author Index 2024	5
Impact of Selective Serotonin-Reuptake Inhibitors in Hemorrhagic Risk in Anticoagulated Patients Taking Non–Vitamin K Antagonist Anticoagulants	5
Valproic Acid–Associated Hyperammonemia	5
Fixed-Dose Brexpiprazole and Sertraline Combination Therapy for the Treatment of Posttraumatic Stress Disorder	5
Hematological and Other Cancers in People Using Clozapine	5
Piracetam for Risperidone-associated Hypersalivation	5
Lithium-Associated Nephrogenic Diabetes Insipidus or Catatonic Stereotypical Drinking?	5
Breaking the Cycle	5
Positive Pyramidal Sign as an Unexpected Presentation in Antipsychotic-Induced Acute Dystonia	4
Protracted Psychiatric Complications Including Psychosis in a Middle-Aged Man After COVID-19 Vaccination	4
Aripiprazole Withdrawal–Associated Restless Legs Syndrome During Clozapine Treatment in an Adolescent With Schizoaffective Disorder	4
Differentiating Depressive Symptoms From Side Effects in Individuals With Major Depressive Disorder With Postpartum Onset	4
Malignant Catatonia and Neuroleptic Malignant Syndrome Overlap in the Emergency Department	4
Combination of Long-Acting Injectable Antipsychotics in the Treatment of Psychiatric Disorders—A Systematic Review of the Literature and Case Series	4
The Association Between Mood Stabilizers, Sleep Quality, and Functioning in Patients With Remitted Bipolar Disorder	4
Factors Predicting the Efficacy of Valbenazine and Exacerbation of Tardive Dyskinesia After Valbenazine Discontinuation in Japanese Patients	4
Characterization of Extended-Release Lorazepam	4
Neurotoxicity Related to Multidrug Association: A Case Report	4
Response to Letter to the Editors From Prof D. Taylor	4
The Need for Non-profit Psychiatric Drug Discovery and Development	4
Clonidine and Trihexyphenidyl in Clozapine-induced Hypersalivation	4
Clozapine-associated Retrograde Ejaculation	4
Human Abuse Potential of Single Oral Doses of Sunobinop, a Novel, Highly Potent, and Selective Partial Agonist for Nociceptin/Orphanin-FQ Peptide (NOP) Receptors	4
The Potential Role of Fluvoxamine in Clozapine-Associated Constipation	4
Deutetrabenazine Provides Long-Term Benefit for Tardive Dyskinesia Regardless of Underlying Condition and Dopamine Receptor Antagonist Use	4
Liraglutide in Obese or Overweight Individuals With Stable Bipolar Disorder	4
Reply to “Progress on Pharmacogenetic Tests for Antidepressant Drug Selection Requires Properly Designed Studies”	4
Detecting Anxious Distress, an Important Mood Specifier	4
Fluoxetine and Sertraline Inhibit Height Growth and Growth Hormone Signaling During Puberty	4
Antidepressant-Induced Sexual Dysfunction in Adults	4
Prophylactic Management of Women With Bipolar Disorder During Pregnancy and the Perinatal Period	4
Lumbosacral Plexopathy in Clozapine Overdose: A Case Report	4
Seizure, Rhabdomyolysis, and Hypoglycemia in a Patient With Venlafaxine Poisoning	4
Myoclonic Movements and Catatonic-Like Symptoms After Abrupt Cessation of Clozapine	4
Exploring the Addictive Potential of Tranylcypromine	4
Reversible Valproic Acid–Associated Cerebral Pseudoatrophy in a 53-Year-Old Male With Bipolar I Disorder	4
Reply: Misidentified Dopamine Agonists Undermine Investigation Into Aripiprazole Link With Impulse Control Disorders	4
Sleep Quality After Quetiapine Augmentation in Patients With Treatment-Resistant Depression and Personality Disorders	4
At Last, a Nondopaminergic Agent for the Treatment of Schizophrenia: The Combination of Xanomeline and Trospium (Cobenfy)	4
The Potential Benefits of Chromium and Selenium Supplementation Across Psychiatric Disorders and Symptoms	4
Comparison of Psychiatric and Clinical Profiles Between People Who Use Synthetic Cathinones and Methamphetamine	4
Efficacy of Brexpiprazole Combination Therapy on Anhedonia in a Case of Treatment Resistant Bipolar II Depression	4
You Shall Not Turn a Blind Eye to Intraocular Pressure	4
Improving Result Turnaround Time as a Crucial Factor to Increasing Clozapine Therapeutic Drug Monitoring in Hospitalized Patients	3
A Review of Evidence and an Algorithm for Use of Psychopharmacology in the Treatment of Tobacco Use Disorder in Behavioral Health Settings	3
Severe Alprazolam Withdrawal With Delirium and Psychosis	3
How Does Drug Company Marketing Affect Physician Prescribing?	3
Ketamine as a Potential Neuromodulatory Treatment for Long COVID Neuropsychiatric and Neuropathic Symptoms	3
Catatonia Associated With Valbenazine Treatment	3
Ischemic Priapism With Therapeutic Serum Concentrations of Psychotropic Medications	3
Hepatic Safety of Ketamine and Esketamine for Treatment-Resistant Depression	3
Neutropenia Associated With Trazodone	3
Efficacy of Low-Dose Adjunctive Methylphenidate Extended-Release on Cognition and Functioning in Individuals With Schizophrenia	3
Panic Disorder Seeks More Specific Drugs for Treatment	3
Adolescent Aripiprazole-Associated Rhabdomyolysis Without Neuroleptic Malignant Syndrome	3
Journal of Clinical Psychopharmacology Updates	3
Ketamine and Esketamine for Depression in Daily Practice	3
Evaluating the Quality of Randomized Controlled Trials	3
Relapse of Tardive Dyskinesia Following Successful Treatment With Amantadine	3
Managing a Treatment-Resistant Schizophrenia Spectrum Disorder With a Hormonal Twist in a Female Patient	3
Toxidrome of an Easily Obtainable Nootropic	3
Journal of Clinical Psychopharmacology Updates	3

Critical Lithium Level in a Nontoxic Outpatient	3
Journal of Clinical Psychopharmacology Updates	3
Reply to “Xanomeline/Trospium Combination: Not Non-dopaminergic but a Novel Antidopaminergic Treatment for Schizophrenia”	3
Modafinil Use in an Adolescent With Major Depressive Disorder	3
Risk of Neutropenia Associated With Duloxetine	3
Premature Ejaculation After Discontinuation of Venlafaxine in a Case of Bipolar Depression	3
Aripiprazole-Associated Hypomania in a Patient With Major Depressive Disorder	3
Concentrations of Fluoxetine Enantiomers Decline During Pregnancy and Increase After Birth	3
Imipramine	3
Assessing Adherence to Clozapine	3
A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants	3
Health Alert: Microdose Products Leading to Acute Illness and Hospitalizations Across the United States	3
Recurrent Guaifenesin-Associated Nephrolithiasis Complicates Dextromethorphan Abuse	3
Semaglutide Misuse in Atypical Anorexia Nervosa—A Case Report	3
Global Insights Into Antipsychotic Research	3
Impact of Prior Psychiatric Diagnoses on the Incidence of Dissociative Symptoms Associated With Analgesic Ketamine Infusions in a Surgical Intensive Care Unit	3
REL-1017 (Esmethadone) May Rapidly Reduce Dissociative Symptoms in Adults With Major Depressive Disorder Unresponsive to Standard Antidepressants	3
A Case of Acute Conditioned Dyspnea During Tracheostomy Weaning Treated Successfully With Adjunctive Mirtazapine	3
Pramipexole as an Augmentation Strategy to Electroconvulsive Therapy in the Treatment of Bipolar Depression Complicated With Parkinsonism	3
Tardive Dyskinesia Suppressed With Ginkgo Biloba	3
Reply to “All Patients With Catatonia Deserve Proper Diagnosis, Theragnosis, and Prognosis”	3
Toward Precision Psychiatry	3
Question	3
α-PVP Associated Psychosis	3
Phase 2b Trial of the PDE10A Inhibitor MK-8189 in People With an Acute Episode of Schizophrenia	3
A First Trimester Exposure to Ketamine and Esketamine for Depression	3
Second-Generation Antipsychotic Long-Acting Injection Reduced the Time of Restrictive Interventions in Patients With Schizophrenia	3
Effectiveness and Tolerability of Lurasidone for Bipolar Types I and II and Other Specified Bipolar Depression	3
High-Dose Methylphenidate and Carboxylesterase 1 Genetic Variability in Patients With Attention-Deficit/Hyperactivity Disorder	3
Venlafaxine-Associated Rhabdomyolysis	3
The Impact of Once Daily Dosing on Protein Binding of Clozapine and Norclozapine	3
The Management of Very Early-Onset Schizophrenia With an Olanzapine and Amisulpride Combination	3
Growing Concerns Over Valproate Teratogenicity Present an Opportunity for Lithium	3
Characteristics of Ongoing Clinical Trials of Psychogenic Substances for Psychiatric Disorders	3
New Onset of Seizures and Psychosis in a Patient Who Is Coprescribed Atomoxetine and Bupropion	3
Preventive Effects of Ramelteon, Suvorexant, and Lemborexant on Delirium in Hospitalized Patients With Physical Disease	3
Hypotension and Peripheral Edema With Moclobemide	2
Question	2
Amantadine as an Alternative to VMAT2 Inhibitors for Tardive Dyskinesia in Patients at Risk of Depression and Suicidality	2
Sleep-wake Disorders	2
Effects of Age, Sex, and Comedication on the Plasma Concentrations of Olanzapine in Chinese Patients With Schizophrenia Based on Therapeutic Drug Monitoring Data	2
Beyond Clozapine	2
Safety of Adjunct Low-Dose Methylphenidate Extended-Release for Cognitive Deficits in Stable Schizophrenia	2
Lethal Acute Colonic Pseudo-Obstruction in a Patient Using a Combination of Olanzapine and Clozapine	2
Acute Psychosis After Immunization With Whole-Virion Inactivated COVID-19 Vaccine; A Case Report From Central India	2
Serotonin Synthesis Amplification to Augment the Therapeutic Efficacy of Serotonin Reuptake Inhibitor Antidepressants	2
The Impact of Antidepressant Medications on Sleep in Children	2
Pleural Effusion Associated With Divalproex Sodium	2
A Call for the Study of Zuranolone as a Novel Treatment for Premenstrual Dysphoric Disorder	2
Critical Feedback on Article by Lee and Colleagues: “Long-Term Outcome of Clozapine in Treatment-Resistant Schizophrenia”	2
52-Week Open-Label Safety and Tolerability Study of Centanafadine Sustained Release in Adults With Attention-Deficit/Hyperactivity Disorder	2
The Efficacy of Methylphenidate Use in Children Diagnosed With Attention Deficit Hyperactivity Disorder With Emotional Impulsivity Symptoms	2
Effect of Coffee and Chocolate Ingestion on Clozapine Dose and on Plasma Clozapine and Norclozapine Concentrations in Clinical Practice	2
Antidepressant Poisoning Trends in Pediatric Intensive Care	2
Fifty-Nine-Year-Old Woman With Concurrent Administration of Cobicistat and Dexamethasone Potentially Leading to Mania	2
Agomelatine as an Effective Intervention for Psychiatric Symptoms in Postacute Sequelae of COVID-19	2
Semaglutide-Mediated Lithium Toxicity	2
Painful Ejaculation Associated With Atomoxetine and Bupropion	2
Exploratory Case Series Assessing the Potential Interaction Between Lithium and Sodium-Glucose Cotransporter-2 Inhibitors	2
Blepharospasm Arising From Escitalopram Use	2
Variability in Response to Antidepressants	2
Efficacy and Safety of Valbenazine in Japanese Patients With Tardive Dyskinesia and Schizophrenia/Schizoaffective Disorder or Bipolar Disorder/Depressive Disorder	2
Group-Based Trajectory Modeling to Identify Patterns of Antipsychotic-Associated Weight Gain Among Children and Adolescents	2
Evaluating the Effectiveness of Cyproheptadine on Acute Neuroleptic-induced Akathisia	2
Tirzepatide-Associated Lithium Toxicity Necessitating Hemodialysis in Previously Stable Bipolar I Disorder	2
Clozapine-Associated Eosinophilia at a Movement Disorders Clinic	2
Obesity Associated With Symptomatic Remission in Clozapine-Treated Individuals With Treatment-Resistant Schizophrenia	2
Unraveling the Optimal Treatment Approach for Depression in Schizophrenia Spectrum	2
Impact of a Caffeine Restriction Policy on Inpatients With Schizophrenia	2
Severe Urinary Retention Associated With Combined Treatment With Escitalopram and Quetiapine	2
Metabolic Problems Among People With Treatment-Resistant Schizophrenia are Not Unique to Clozapine	2
Current Clinical Psychopharmacology Integrated Practice	2
Lemborexant Attenuates Methamphetamine Craving and Euphoria	2
Comparative Pharmacovigilance Analysis of Pulmonary Embolism Across Antipsychotics in VigiBase	2
Evaluation and Comparison of the Effectiveness of Atropine Eye Drops, Ipratropium Bromide Nasal Spray, and Amitriptyline Tablet in the Management of Clozapine-Associated Sialorrhea in Patients With Re	2
Question	2
Effects of a Single Dose of Ayahuasca in College Students With Harmful Alcohol Use	2
A Phase 2 Randomized Trial of NBI-1065846 (TAK-041) in Patients With Anhedonia Associated With Major Depressive Disorder	2
Fact Versus Fear	2
Antimicrobial Exposure and Risk for Incident Major Depressive Disorder	2
Myocarditis After Clozapine Initiation and mRNA SARS-CoV-2 Vaccination	2
Levodopa Augmentation of Antipsychotics for Persistent Negative Symptoms in Schizophrenia	2
Effects of Adjunctive Brexpiprazole in Major Depressive Disorder Analyzed by Baseline Anxiety Level	2
Zuranolone Concentrations in the Breast Milk of Healthy, Lactating Individuals	2
Effects of Adjunctive Brexpiprazole on Individual Depressive Symptoms and Functioning in Patients With Major Depressive Disorder and Anxious Distress	2
Question	2
Response of Gambling Disorder to Semaglutide	2
Cariprazine-Associated Obsessive-Compulsive Symptoms in a Patient With Bipolar Disorder	2
Risk of Mania After Methylphenidate in Patients With Bipolar Disorder	2
Advancing the Development of New Medications to Treat Psychiatric Illness	2
Question	2
Pimavanserin Exposure-Response Analyses in Patients With Schizophrenia	2
κ-Opioid Receptor Plasma Levels Are Associated With Sex and Diagnosis of Major Depressive Disorder But Not Response to Ketamine	2
Citalopram-Associated Hyponatremia Presenting as Distal Extremity Numbness	2
Statistical Versus Clinical Significance	2